Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation

BACKGROUND: Uncommon epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) is a rare subset of NSCLC. The aim of this study was to investigate the prevalence, characteristics, and clinical outcomes of metastatic NSCLC harboring uncommon EGFR mutation at Thailand’s largest...

Descripción completa

Detalles Bibliográficos
Autores principales: Chantharasamee, J., Poungvarin, N., Danchaivijitr, P., Techawatanawanna, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637469/
https://www.ncbi.nlm.nih.gov/pubmed/31315599
http://dx.doi.org/10.1186/s12885-019-5913-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637469/
https://www.ncbi.nlm.nih.gov/pubmed/31315599
http://dx.doi.org/10.1186/s12885-019-5913-9

Ejemplares similares